Stock Price
2.47
Daily Change
-0.02 -0.80%
Monthly
-10.51%
Yearly
-18.21%
Q1 Forecast
2.48

Mesoblast reported $784.68M in Assets for its fiscal semester ending in June of 2025.





Assets Change Date
Avita Medical AUD 58.13M 21.58M Jun/2025
Clinuvel Pharmaceuticals AUD 231.12M 19.44M Jun/2024
Cochlear AUD 2.82B 38.9M Jun/2025
CSL USD 39.4B 957M Jun/2025
Pacific Edge NZD 34.66M 2.37M Dec/2025
Paradigm Biopharmaceuticals AUD 24.57M 10.79M Jun/2025
PYC Therapeutics AUD 183.28M 115.05M Jun/2025
Ramsay Health Care AUD 22.48B 1.82B Jun/2025
Sonic Healthcare AUD 15.38B 550.57M Dec/2024
Starpharma Holdings AUD 25.42M 4.19M Jun/2025
Telix Pharmaceuticals AUD 1.52B 770.47M Dec/2024